Cargando…

1294. Acceptability and Feasibility of a Pharmacist-led Pre-exposure Prophylaxis Program in the Midwestern United States

BACKGROUND: Despite evidence that HIV pre-exposure prophylaxis (PrEP) substantially reduces the risk of infection in at-risk populations, significant barriers exist to its prescription and use. Utilizing pharmacists may help increase patient access to PrEP services. We designed and implemented a nov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bares, Sara, Havens, Joshua, Scarsi, Kimberly, Klepser, Donald, Swindells, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252523/ http://dx.doi.org/10.1093/ofid/ofy210.1127

Ejemplares similares

Acceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United States
por: Havens, Joshua P, et al.
Publicado: (2019)

Midwest pharmacists’ familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV
por: Broekhuis, Jordan M., et al.
Publicado: (2018)

Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States
por: Dong, Betty J, et al.
Publicado: (2019)

A pharmacist-led medication switch protocol in an academic HIV clinic: patient knowledge and satisfaction
por: Lee, Sarah S., et al.
Publicado: (2018)

Response to Dong et al.
por: Havens, Joshua P, et al.
Publicado: (2020)

Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Patients With HIV-1 Infection and Ongoing Substance Use Disorder: The BASE Study
por: Havens, Joshua P, et al.
Publicado: (2023)

Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis
por: Selvaraj, Shailendra V, et al.
Publicado: (2020)

Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)
por: MacDonald, Calum B., et al.
Publicado: (2023)

US Human Immunodeficiency Virus (HIV) Practitioners’ Recommendations Regarding Condomless Sex in the Era of HIV Pre-Exposure Prophylaxis and Treatment as Prevention
por: Schreier, Travis, et al.
Publicado: (2019)

Acceptability, Feasibility, and Appropriateness of Implementation of Long-acting Injectable Antiretrovirals: A National Survey of Ryan White Clinics in the United States
por: Tarfa, Adati, et al.
Publicado: (2023)

Community pharmacists’ acceptance of prescribing pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)
por: Booker, Connor, et al.
Publicado: (2023)

1557 Impact of HIV Pharmacist Reconcilation on Correction of Antiretroviral Prescription Errors Among Hospitalized HIV-Infected Patients
por: Batra, Rishi, et al.
Publicado: (2014)

Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya
por: Ngure, Kenneth, et al.
Publicado: (2017)

The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?
por: Scarsi, Kimberly K., et al.
Publicado: (2021)

The Effect of Pharmacist-Led Intervention on Surgical Antibacterial Prophylaxis (SAP) at an Orthopedic Unit
por: Fésüs, Adina, et al.
Publicado: (2021)

Minutes of the PPC meeting held on 1.2.94
por: Manglunki, D
Publicado: (1994)

A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV
por: Bares, Sara H., et al.
Publicado: (2022)

942. Lung Cancer Screening in at-risk patients with HIV in a Midwestern Clinic
por: Lopez, Wilfredo, et al.
Publicado: (2020)

Pre-exposure prophylaxis in Southern Africa: feasible or not?
por: Venter, Willem Daniel François, et al.
Publicado: (2015)

A Midwestern Academic HIV Clinic Operation during the COVID-19 Pandemic: Implementation Strategy and Preliminary Outcomes
por: Fadul, Nada, et al.
Publicado: (2021)

2603. Acceptance of Pharmacist-Led Stewardship Recommendations for Patients with Community-Acquired Pneumonia
por: Walker, Ramara E, et al.
Publicado: (2023)

Co-design and feasibility of a pharmacist-led minor ailment service
por: Dineen-Griffin, Sarah, et al.
Publicado: (2021)

Acceptability and feasibility of the CHARISMA counseling intervention to support women’s use of pre-exposure prophylaxis: results of a pilot study
por: Wilson, Ellen K., et al.
Publicado: (2021)

Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives
por: Roche, Stephanie D., et al.
Publicado: (2021)

Understanding the Feasibility, Acceptability, and Efficacy of a Clinical Pharmacist-led Mobile Approach (BPTrack) to Hypertension Management: Mixed Methods Pilot Study
por: Buis, Lorraine R, et al.
Publicado: (2020)

Education and clinical pharmacist-led management strategies for the risk and prophylaxis of venous thromboembolism in general surgery
por: Kiracı, Zeynep Karaburç, et al.
Publicado: (2023)

A Retrospective Comparison of HIV Pre-exposure Prophylaxis (PrEP) Outcomes Between a Pharmacist-led Telehealth Clinic and In-person Clinic in a Veteran Population
por: Greenwell, Kellen, et al.
Publicado: (2023)

IS1294 Reorganizes Plasmids in a Multidrug-Resistant Escherichia coli Strain
por: Pan, Yushan, et al.
Publicado: (2021)

Enhancing domestic violence advocates’ ability to discuss HIV pre-exposure prophylaxis (PrEP): Feasibility and acceptability of an educational intervention
por: Willie, Tiara C, et al.
Publicado: (2022)

1989. Impact of Pharmacist-Led β-Lactam Allergy Clarification Interview on Optimizing Preoperative Antibiotic Prophylaxis
por: Kwiatkowski, Shaina, et al.
Publicado: (2019)

Community Pharmacists’ Experiences and Perception about Transitions of Care from Hospital to Home in a Midwestern Metropolis
por: Vossen, Rachel K., et al.
Publicado: (2021)

Ambulatory hernia repair: a study of 1294 patients in a single institution
por: Hajri, Mohamed, et al.
Publicado: (2022)

The tumor suppressor role and ceRNA network of miR-1294 in cancer
por: MAO, YUNAN, et al.
Publicado: (2023)

Feasibility and Acceptability of an mHealth-Based Approach as an HIV Prevention Strategy Among People Who Use Drugs on Pre-Exposure Prophylaxis
por: Shrestha, Roman, et al.
Publicado: (2020)

COVID-19 host genetic risk study conducted at community pharmacies: Implications for public health, research and pharmacists’ scope of practice
por: Beam, Teresa A., et al.
Publicado: (2023)

Opportunities to Increase Access to HIV Prevention: Evaluating the Implementation of Pharmacist-Initiated Pre-exposure Prophylaxis in California
por: Hunter, Lauren A, et al.
Publicado: (2023)

Impact of pharmacist-led antibiotic stewardship interventions on compliance with surgical antibiotic prophylaxis in obstetric and gynecologic surgeries in Nigeria
por: Abubakar, Usman, et al.
Publicado: (2019)

Nurse-led safer opioid supply and HIV pre-exposure prophylaxis: a novel pilot project
por: Haines, Marlene, et al.
Publicado: (2022)

Feasibility, acceptability and potential effectiveness of an information technology-based, pharmacist-led intervention to prevent an increase in anticholinergic and sedative load among older community-dwelling individuals
por: van der Meer, Helene G., et al.
Publicado: (2018)

Feasibility, accessibility and acceptability a pharmacist-led ear health intervention at rural community pharmacies (LISTEN UP): a mixed-methods study in Queensland, Australia
por: Taylor, Selina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t56injcaehsk72u73lnpp0ia4a